The first Australian batch of a COVID-19 mRNA vaccine will be manufactured in Victoria for clinical trials, using a vaccine candidate developed by Victorian researchers.
A global logistics company is set to invest $147 million to expand its Asia Pacific headquarters in Melbourne, in a move which will strengthen Victoria’s position as a market of choice for businesses in the food and fibre, transport, distribution and logistics industries.
A newly established Scientific Advisory Group will bring together leading local and global vaccine experts, including an award-winning immunologist and virologist, to provide advice on mRNA manufacturing capability in Victoria.
In an exciting development for Victoria’s world leading medical research sector, Hudson Institute is now home to new cutting edge technology that will provide unprecedented genomic capacity to study inflammatory diseases and microbial diversity.
A global health technology and caregiving startup from Singapore has picked Melbourne for its Australian headquarters, further strengthening the State’s thriving world class health technology sector.
Swinburne University of Technology will partner with metal additive manufacturing specialist Amaero International to undertake a project on coatings for space vehicle components – another great collaboration between the tertiary and private sectors.
Monash University has signed a Memorandum of Understanding (MoU) with global energy company ENGIE, building on the strong track record of collaborations between the tertiary and private sectors.